Trial Profile
Evaluate reactogenicity and immunogenicity of adjuvanted influenza vaccine in elderly adults previously vaccinated with the same candidate vaccine. Fluarix administered in young and elderly adults will be used as reference
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GSK
- 28 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 12 Dec 2006 Status change
- 03 Dec 2006 New trial record.